Lantern Pharma Investors
Lantern Pharma is an Angel Group based in Dallas, Texas, United States, founded in 2013 The organization focuses on advancing innovative therapies in the field of oncology With a significant investment scale of $26,250,000, Lantern Pharma aims to enhance the development of precision medicine for cancer treatment The groups commitment to leveraging advanced technologies and data analytics positions it as a leader in the biotechnology sector Through strategic partnerships and investments, Lantern Pharma is dedicated to improving patient outcomes in cancer care
Founded Date:
2013
Last Funding Type:
Series D
Headquarters:
USA
Investors Number:
4
Technology:
['BioTech & HealthTech']
Employee Number:
11-50
Industry:
FemTech
Estimated Revenue:
$0.068B
Last Funding Date:
2021-01-14
Funding Status:
IPO
Investor Type:
Angel Groups
Total Funding:
50085302